PET kinetic analysis - Compartmental model

Annals of Nuclear Medicine

Volumn 20, Issue 9, 2006, Pages 583-588

  Watabe, Hiroshi ^a   Ikoma, Yoko ^b   Kimura, Yuichi ^c   Naganawa, Mika ^c,d   Shidahara, Miho ^b  

^a NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

^b NATIONAL INSTITUTE OF RADIOLOGICAL SCIENCES   (Japan)

^c TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^d JAPAN SOCIETY FOR THE PROMOTION OF SCIENCE   (Japan)

Author keywords

Compartmental model; PET; Pharmacokinetics

Indexed keywords

FLUORODEOXYGLUCOSE F 18; TRACER;

COMPARTMENT MODEL; INTRAARTERIAL DRUG ADMINISTRATION; KINETICS; MATHEMATICAL MODEL; MOLECULAR IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; REVIEW;

COMPUTER SIMULATION; DATA INTERPRETATION, STATISTICAL; FLUORODEOXYGLUCOSE F18; HUMANS; KINETICS; MAGNETIC RESONANCE IMAGING; MODELS, THEORETICAL; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; RADIOISOTOPES; TELENCEPHALON; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 33845647144     PISSN: 09147187     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02984655     Document Type: Review

References (41)

1. Luker G, Piwnica-Worms D. Molecular imaging in vivo with PET and SPECT. Acad Radiol November 2001; 8: 4-14.
2. Dobrucki L, Sinusas A. Molecular imaging. A new approach to nuclear cardiology. Q J Nucl Med Mol Imaging 2005; 49 (1): 106-115.
3. Weissleder R. Molecular imaging in cancer. Science 2006; 312 (5777): 1168-1171.
4. Kety S. The theory and applications of the exchange of inert gas at the lungs and tissues. Pharmacol Rev 1951; 3: 3-41.
5. 18F]fluorodeoxyglucose method for the measurement of local cerebral glucose utilization in man. Circ Res 1979; 44 (1): 127-137.
6. Mintun M, Raichle M, Martin W, Herscovitch P. Brain oxygen utilization measured with O-15 radiotracers and positron emission tomography. J Nucl Med 1984; 25 (2): 177-187.
7. Mintun M, Raichle M, Kilbourn M, Wooten G, Welch M. A quantitative model for the in vivo assessment of drug binding sites with positron emission tomography. Ann Neurol 1984; 15 (3): 217-227.
8. Eriksson L, Holte S, Bohm C, Kesselberg M, Hovander B. Automated blood sampling systems for positron emission tomography. IEEE Nucl Sci 1988; 35 (1): 703-707.
9. Kudomi N, Choi E, Yamamoto S, Watabe H, Kim K, Shidahara M, et al. Development of a GSO detector assembly for a continuous blood sampling system. IEEE Trans Nucl Sci 2003; 50 (1): 70-73.
10. 11C]flumazenil kinetics for the estimation of ligand transport rate and receptor distribution using positron emission tomography. J Cereb Blood Flow Metab 1991; 11 (5): 735-744.
11. 11C]MDL 100,907. J Cereb Blood Flow Metab 2000; 20 (6): 899-909.
12. 18F]6-fluoro-L-DOPA metabolites in nonhuman primate: implications for the kinetics of therapeutic L-DOPA. Front Biosci 2004; 9: 505-512.
13. Patlak C, Blasberg R. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. Generalizations. J Cereb Blood Flow Metab 1985; 5 (4): 584-590.
14. 11C]methyl-(-)-cocaine PET studies in human subjects. J Cereb Blood Flow Metab 1990; 10 (5): 740-747.
15. Cunningham V, Jones T. Spectral analysis of dynamic PET studies. J Cereb Blood Flow Metab 1993; 13 (1): 15-23.
16. Murase K. Spectral analysis: principle and clinical applications. Ann Nucl Med 2003; 17 (6): 427-434.
17. Gunn R, Gunn S, Turkheimer F, Aston J, Cunningham V. Positron emission tomography compartmental models: a basis pursuit strategy for kinetic modeling. J Cereb Blood Flow Metab 2002; 22 (12): 1425-1439.
18. Lammertsma A, Jones T, Frackowiak R, Lenzi G. A theoretical study of the steady-state model for measuring regional cerebral blood flow and oxygen utilisation using oxygen-15. J Comput Assist Tomogr 1981; 5 (4): 544-550.
19. 18F]cyclofoxy and positron emission tomography. J Cereb Blood Flow Metab 1993; 13 (1): 24-42.
20. 11C]raclopride: optimization and signal-tonoise considerations. J Nucl Med 2000; 41 (3): 522-530.
21. 15O and dynamic positron-emission tomography. Strategy for quantification in relation to the partial-volume effect. Circulation 1988; 78 (1): 104-115.
22. 13N-ammonia and PET: comparison of tracer models. J Nucl Med 1999; 40 (6): 1045-1055.
23. 15O]water. IEEE Trans Med Imaging 2001; 20 (3): 164-174.
24. Naganawa M, Kimura Y, Ishii K, Oda K, Ishiwata K, Matani A. Extraction of a plasma time-activity curve from dynamic brain PET images based on independent component analysis. IEEE Trans Biomed Eng 2005; 52 (2): 201-210.
25. Watabe H, Itoh M, Cunningham V, Lammertsma A, Bloomfield P, Mejia M, et al. Noninvasive quantification of rCBF using positron emission tomography. J Cereb Blood Flow Metab 1996; 16 (2): 311-319.
26. Bella ED, Clackdoyle R, Gullberg G. Blind estimation of compartmental model parameters. Phys Med Biol 1999; 44 (3): 765-780.
27. 11C]raclopride studies. J Cereb Blood Flow Metab 1996; 16 (1): 42-52.
28. Lammertsma A, Hume S. Simplified reference tissue model for PET receptor studies. Neuroimage 1996; 4 (3 Pt 1): 153-158.
29. 11C]carfentanil: reference-tissue methods. Nucl Med Biol 2003; 30 (2): 177-186.
30. 11C](R)-PK11195 studies. J Cereb Blood Flow Metab 2006.
31. Yokoi T, Iida H, Itoh H, Kanno I. A new graphic plot analysis for cerebral blood flow and partition coefficient with iodine-123-iodoamphetamine and dynamic SPECT validation studies using oxygen-15-water and PET. J Nucl Med 1993; 34 (3): 498-505.
32. Ichise M, Toyama H, Innis R, Carson R. Strategies to improve neuroreceptor parameter estimation by linear regression analysis. J Cereb Blood Flow Metab 2002; 22 (10): 1271-1281.
33. Slifstein M, Laruelle M. Effects of statistical noise on graphic analysis of PET neuroreceptor studies. J Nucl Med 2000; 41 (12): 2083-2088.
34. Gunn R, Lammertsma A, Hume S, Cunningham V. Parametric imaging of ligand-receptor binding in PET using a simplified reference region model. Neuroimage 1997; 6 (4): 279-287.
35. 15O-water and PET using the basis function method. J Nucl Med 2005; 46 (7): 1219-1224.
36. Breier A, Su T, Saunders R, Carson R, Kolachana B, Bartolomeis de A, et al. Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method. Proc Natl Acad Sci USA 1997; 94 (6): 2569-2574.
37. 11C]raclopride: combined PET-microdialysis studies. J Cereb Blood Flow Metab 1997; 17 (9): 932-942.
38. 11C]tracer single-acquisition positron emission tomography studies. J Cereb Blood Flow Metab 2001; 21 (12): 1480-1492.
39. 15O-labeled oxygen and water during a single PET scan - a validation study and error analysis in anesthetized monkeys. J Cereb Blood Flow Metab 2005; 25: 1209-1224.
40. 18F-FHBG for quantitating herpes simplex virus type 1 thymidine kinase reporter gene expression in living animals using PET. J Nucl Med 2004; 45 (9): 1560-1570.
41. Richard J, Zhou Z, Chen D, Mintun M, Piwnica-Worms D, Factor P, et al. Quantitation of pulmonary transgene expression with PET imaging. J Nucl Med 2004; 45 (4): 644-654.